SUBSCRIBE
SUBSCRIBE
News   Deals

GlaxoSmithKline Gets US Okay to Buy Heart Drug Maker Reliant Pharmaceuticals, Inc.

December 17, 2007 | 
1 min read
WASHINGTON, Dec 14 (Reuters) - U.S. antitrust authorities have cleared GlaxoSmithKline Plc (GSK.L: Quote, Profile, Research) to buy privately held heart drug specialist Reliant Pharmaceuticals.
Mergers & acquisitions
GlaxoSmithKline
MORE ON THIS TOPIC
Creative design. Desperate employee, office worker standing near question mark symbolizing business struggles, options. Choosing strategy for achieving goal. Concept of business, career development
Earnings
Tariffs Keep Biogen Execs Busy in Q1 but Impacts Expected To Be Minimal
May 1, 2025
 · 
3 min read
 · 
Annalee Armstrong
Paying double wages or giving double money, greed and lust, double work for double wages, one person splitting into two and claiming both
Deals
Novartis Strikes on M&A, Leading a Line of Big Pharmas With Cash to Spend
April 30, 2025
 · 
5 min read
 · 
Annalee Armstrong
Mergers & acquisitions
Novartis Drops up to $1.7B to Bolster Oligo Pipeline With Regulus Buy
April 30, 2025
 · 
2 min read
 · 
Tristan Manalac
Poznan, Poland - 5 October 2024: GSK -Glaxosmithkline headquarters office building in Poznan.
Earnings
GSK Optimistic About M&A Prospects Despite Trump Tariff Threats
April 30, 2025
 · 
2 min read
 · 
Tristan Manalac